About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 4NCT00048776

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Juvenile secondary Raynaud's (ray-knows) Phenomenon is a disorder of the blood vessels in the fingers and sometimes can affect the toes, nose, or ears. Children with secondary Raynaud's Phenomenon hav...

Lead sponsor: Otsuka America Pharmaceutical•19 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Otsuka America Pharmaceutical

Age

5 - 16 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•5 to 16 years old
•fulfill diagnostic criteria for primary or secondary Raynaud's

Related studies

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

NCT02396238 · Scleroderma, Systemic Sclerosis, and more

COMPLETEDPhase 2

PF-00489791 For The Treatment Of Raynaud's

NCT01090492 · Raynaud's Disease, Peripheral Vascular Disease

Nova Cold Hands Raynaud's Disorder, a Disease Which Results in Decreased Blood Flow to the Hands and Feet.

NCT02615964 · Raynaud's Disease

A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

NCT00577304 · Raynaud's Disease, Raynaud's Disease Secondary to Scleroderma, and more

COMPLETEDPhase 2

Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

NCT00378521 · Raynaud's Disease, Raynaud's Disease Secondary to Scleroderma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 19, 2005Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment75

Start dateOct 2001

Last updatedJul 19, 2005

Condition

Raynaud's Disease

Locations shown

Advanced Medical Clinical Therapeutics

Anchorage, Alaska

Advanced Medical Research Institute

Fresno, California

Madera Family Medical Group

Madera, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 19, 2005Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions